CINECA IRIS Institutional Research Information System

BONUCCELLI, UBALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.899
AS - Asia 16.033
EU - Europa 13.717
SA - Sud America 2.216
AF - Africa 669
OC - Oceania 88
Continente sconosciuto - Info sul continente non disponibili 13
Totale 70.635
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.906
SG - Singapore 4.949
IT - Italia 4.906
CN - Cina 4.617
HK - Hong Kong 2.757
SE - Svezia 1.951
BR - Brasile 1.854
VN - Vietnam 1.299
DE - Germania 1.297
BG - Bulgaria 1.199
CA - Canada 837
GB - Regno Unito 773
TR - Turchia 681
FI - Finlandia 654
FR - Francia 634
RU - Federazione Russa 601
UA - Ucraina 573
KR - Corea 520
IN - India 327
AT - Austria 320
CH - Svizzera 235
CI - Costa d'Avorio 206
JP - Giappone 187
NG - Nigeria 143
BD - Bangladesh 126
AR - Argentina 116
NL - Olanda 116
PL - Polonia 104
IQ - Iraq 91
ZA - Sudafrica 84
MX - Messico 80
ES - Italia 77
SN - Senegal 76
AU - Australia 71
BE - Belgio 70
ID - Indonesia 54
PK - Pakistan 53
CO - Colombia 50
EC - Ecuador 48
VE - Venezuela 44
UZ - Uzbekistan 41
SA - Arabia Saudita 40
MA - Marocco 38
JO - Giordania 30
CZ - Repubblica Ceca 29
IL - Israele 29
KE - Kenya 28
EG - Egitto 27
LT - Lituania 27
CL - Cile 26
IE - Irlanda 26
TW - Taiwan 24
PE - Perù 23
PY - Paraguay 23
PH - Filippine 21
MY - Malesia 20
GR - Grecia 19
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
IR - Iran 17
NZ - Nuova Zelanda 17
AZ - Azerbaigian 16
RO - Romania 16
JM - Giamaica 15
OM - Oman 15
UY - Uruguay 15
BO - Bolivia 12
DZ - Algeria 12
KZ - Kazakistan 12
NP - Nepal 12
PT - Portogallo 12
HU - Ungheria 11
BJ - Benin 10
EU - Europa 10
TT - Trinidad e Tobago 10
AM - Armenia 9
DK - Danimarca 9
GE - Georgia 9
KG - Kirghizistan 9
LB - Libano 9
CR - Costa Rica 8
HN - Honduras 8
PA - Panama 8
RS - Serbia 8
AL - Albania 6
EE - Estonia 6
ET - Etiopia 6
HR - Croazia 6
LV - Lettonia 6
BH - Bahrain 5
BN - Brunei Darussalam 5
GT - Guatemala 5
LK - Sri Lanka 5
PS - Palestinian Territory 5
QA - Qatar 5
SV - El Salvador 5
BY - Bielorussia 4
MD - Moldavia 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
Totale 70.561
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.155
Ashburn 3.836
Fairfield 3.473
Ann Arbor 2.740
Hong Kong 2.718
Singapore 2.647
Houston 2.603
Chandler 2.014
San Jose 1.638
Seattle 1.472
Dallas 1.456
Serra 1.288
Santa Clara 1.286
Cambridge 1.225
Sofia 1.190
Wilmington 1.180
Milan 989
Beijing 933
Shanghai 900
New York 812
Jacksonville 782
Ottawa 692
Hefei 654
Boardman 530
Princeton 526
Seoul 493
Lawrence 462
Medford 437
Los Angeles 405
Lauterbourg 401
Izmir 374
Nanjing 355
Des Moines 317
Ho Chi Minh City 298
Vienna 284
Dearborn 242
Florence 229
Istanbul 223
Bern 213
Abidjan 206
Hanoi 206
Frankfurt am Main 205
Buffalo 202
Dong Ket 192
Pisa 177
Munich 175
Tokyo 170
Council Bluffs 159
Nanchang 158
San Diego 152
Jüchen 145
Lagos 143
São Paulo 142
Redwood City 140
Redondo Beach 139
Rome 139
Lancaster 128
London 126
Helsinki 124
Kunming 101
Bremen 90
Norwalk 84
Shenyang 80
Turku 79
Dakar 76
Ogden 75
Warsaw 72
Pune 66
Boulder 63
Changsha 63
Orem 63
Hebei 62
Chicago 61
Brussels 60
The Dalles 60
Belo Horizonte 59
Guangzhou 59
Columbus 57
Phoenix 50
Tianjin 49
Nuremberg 46
Rio de Janeiro 46
Baghdad 44
Brooklyn 44
Düsseldorf 44
Jiaxing 44
Lucca 43
Johannesburg 41
Fuzhou 40
Montreal 40
Da Nang 39
Washington 37
Chennai 36
San Francisco 36
Tashkent 36
Hangzhou 33
Melbourne 32
Haiphong 31
Porto Alegre 31
Denver 30
Totale 51.902
Salva come PNG Salva come JPEG
Nome #
Il fenomeno dell'abitudine del riflesso trigemino-faciale: confronto tra malattia di Parkinson e atrofia multisistemica. 549
Actigraphic sleep detection: an artificial intelligence approach 371
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 336
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 307
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 273
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 272
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 272
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 271
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 270
Novel MTCYB mutation in a young patient with recurrent stroke-like episodes and status epilepticus. 250
Descrizione di un caso di Neuromiotonia associata a tetania normocalcemica 247
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 246
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 245
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 244
Endothelium and oxidative stress: The Pandora's Box of cerebral (and non-only) small vessel disease? 244
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 239
Occurrence of seizures and EEG interictal epileptiform discharges in AD patients and their correlation with clinical features: a cross-sectional study 234
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 233
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 232
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 229
Gait dynamics in Pisa syndrome and Camptocormia: the role of stride length and hip kinematics 227
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 222
Aerobic rehabilitation program for improving muscle function in Parkinson's disease 221
Thyroid function and oral TRH in amyotrophic lateral sclerosis 219
Epilepsy occurrence in patients with Alzheimer's disease: clinical experience in a tertiary dementia center 219
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 218
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 218
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 218
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 217
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 216
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 214
Cyclic alternating pattern and interictal epileptiform discharges during morning sleep after sleep deprivation in temporal lobe epilepsy 213
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease 212
A case of pelvic floor myoclonic jerk syndrome. 212
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. 212
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 211
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study 209
Intra-arterial tissue plasminogen activator and abciximab in patients with acute basilar artery occlusion 208
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily 205
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study 205
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 205
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 205
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 205
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 204
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 203
Association Between CSF Beta-Amyloid and Apathy in Early-Stage Alzheimer Disease 200
Postpartum headache due to spontaneous cervical artery dissection 199
Cerebral sinus venous thrombosis: Clinical and pathogenetic perspectives from Tuscany 198
DISRUPTION OF SLEEP-WAKE CONTINUUM IN MYOTONIC DYSTROPHY TYPE I: SLEEP MACROSTRUCTURAL AND MICROSTRUCTURAL FINDINGS 197
Reduced luteinizing hormone secretion in women with Parkinson's disease 196
Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients 196
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms? 196
Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry 195
Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol 194
What Does the Brain Have to Keep Working at Its Best? Resilience Mechanisms Such as Antioxidants and Brain/Cognitive Reserve for Counteracting Alzheimer's Disease Degeneration 193
COMPARISON OF THE EFFECTS OF BARBEXACLONE AND PHENOBARBITAL ON EPILEPTIC PATIENTS 193
Sleep Disorders in an elderly population and their relationship with cognitive symptoms: an epidemiological survey 193
A case of sarcoidosis presenting as a non-specific intramedullary lesion 192
Activity-based diary for Parkinson's disease, 191
The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer's Disease. 191
Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation 191
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 190
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 190
Cerebellar ataxia with complete clinical recovery and resolution of MRI lesions related to central pontine myelinolysis: case report and literature review 189
Evidences of Reduced Antioxidant Activity in Patients with Chronic Migraine and Medication-Overuse Headache 188
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 188
Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats 187
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 187
Epidemiology and cerebrovascular events related to cervical and intracranial arteries dissection: the experience of the city of Pisa 187
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 185
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 185
NREM sleep transient events in fronto-temporal dementia: beyond sleep stage architecture 184
Antipsychotic drugs in Huntington's disease 184
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study 183
A case of comorbidity between multiple sclerosis and multiple system atrophy 183
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 183
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. 183
Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease. 183
Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports 182
Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. 182
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial 181
Depressive symptoms in Parkinson's disease 181
Effect of metadoxine on striatal dopamine levels in C57 black mice 181
A whole-brain analysis in de novo Parkinson disease 180
Non-rapid eye movement sleep instability in fronto-temporal dementia 180
Levodopa in the treatment of Parkinson's disease: current controversies 179
Acute and chronic effects of clozapine in essential tremor 179
Perioperative atrial fibrillation and the long-term risk of ischemic stroke 179
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1 179
Oxidative stress assessment in Alzheimer's disease: a clinic setting study 179
Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's disease, 178
Subacute Alzheimer’s disease with prominent white matter involvement. Report of a pathologically-confirmed case 178
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study 177
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients 177
Effect of lacosamide on sleep-wake cycle of adult patients with drug-resistant partial onset epilepsy 177
The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in parkinsonian bradykinesia 177
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 177
Genetics of ischaemic stroke in young adults 177
Plasmatic oxidative stress biomarkers in multiple sclerosis patients with different clinical course 177
Dopamine agonists in the treatment of Parkinson's disease 176
Totale 21.089
Salva come PNG Salva come JPEG
Categoria #
all - tutte 193.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 193.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.925 85 206 101 328 992 673 97 273 338 142 262 1.428
2022/20236.192 756 746 418 522 822 832 56 465 1.012 35 438 90
2023/20244.627 637 501 562 277 621 884 182 185 80 82 197 419
2024/202512.794 56 531 145 717 957 1.140 1.017 724 1.404 1.933 1.586 2.584
2025/202614.123 978 2.061 1.726 1.161 1.372 1.385 2.311 654 602 1.143 486 244
2026/202749 49 0 0 0 0 0 0 0 0 0 0 0
Totale 71.405